# Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/laboratory-safety-of-dupilumab-in-moderate-to-severe-atopic-dermatitis-results/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Andreas Wollenberg,Lisa A. Beck,Andrew Blauvelt,Eric L. Simpson,Z. Chen,Q. Chen,Brad Shumel,Faisal A. Khokhar,Thomas Hultsch,E. Rizova,Ana B. Rossi,Neil M.H. Graham,Gianluca Pirozzi,Yuan Lü,Marius Ardeleanu |
| Citations | 140 |
| DOI | 10.1111/bjd.18434 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjd.18434 |
| OpenAlex ID | https://openalex.org/W2968987915 |
| PMID | 31407311 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Ana B. Rossi](https://scholariq.org/researchers/ana-b-rossi/)

## Paper journal

- [British Journal of Dermatology](https://scholariq.org/journals/british-journal-of-dermatology/)

## Paper primary topic

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

## Paper topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.